What is the treatment for hyperammonemia in an unresponsive patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hyperammonemia in an Unresponsive Patient

In an unresponsive patient with hyperammonemia, immediate initiation of continuous kidney replacement therapy (CKRT) along with nitrogen scavenger medications is the most effective treatment approach to rapidly reduce ammonia levels and prevent irreversible neurological damage. 1, 2

Initial Management

  • Secure airway, breathing, and circulation as the patient is unresponsive 3
  • Immediately discontinue all protein intake to prevent further ammonia production 1, 2
  • Provide adequate non-protein calories through intravenous glucose at 8-10 mg/kg/min and lipids to prevent catabolism 1, 3
  • Target caloric intake of ≥100 kcal/kg daily to prevent protein breakdown 1, 2
  • Collect accurate ammonia samples from free-flowing venous or arterial blood, transported on ice, and processed within 15 minutes to avoid false elevations 1, 3

Pharmacological Therapy

Nitrogen Scavengers

  • Administer intravenous sodium benzoate and sodium phenylacetate as a loading dose over 90-120 minutes followed by maintenance infusion 4
  • Dosage is weight-dependent:
    • For patients <20 kg: 250 mg/kg of each medication 4
    • For patients >20 kg: 5.5 g/m² of each medication 4

Urea Cycle Intermediates

  • Add intravenous L-arginine hydrochloride, especially if urea cycle disorder is suspected 1, 4
    • For OTC and CPS deficiencies: 200 mg/kg 1, 3
    • For ASS and ASL deficiencies: 600 mg/kg 1, 3
  • Add L-carnitine (50 mg/kg loading dose over 90 minutes, then 100-300 mg/kg daily) if organic acidemia is suspected 1, 2

Kidney Replacement Therapy

  • Initiate CKRT immediately in an unresponsive patient with hyperammonemia 5, 1

  • Indications for urgent dialysis include:

    • Ammonia levels >300-400 μmol/L despite medical therapy 5, 2
    • Rapidly deteriorating neurological status or coma 1, 3
    • Persistent high blood ammonia levels >400 μmol/l refractory to medical measures 5
  • Hemodialysis is the most effective method for rapidly reducing blood ammonia levels (95-96% filtration fraction) 1, 2

  • Continuous venovenous hemodialysis (CVVHD) is preferred for hemodynamically unstable patients 2, 3

  • Target blood flow rate of 30-50 ml/min with dialysate flow rate/blood flow rate >1.5 2

  • Continue CKRT until ammonia levels are <200 μmol/L on at least two consecutive hourly measurements 2

Hybrid Therapy Options

  • For patients with severe hemodynamic instability, consider CKRT with ECMO support, which increases blood volume, enables use of larger cannula, and leads to rapid ammonia clearance 5
  • Therapeutic hypothermia combined with KRT may be considered as it slows ammonia production by decreasing metabolism (each 1°C decrease in body temperature reduces basal metabolic rate by 8%) 5

Monitoring During Treatment

  • Check plasma ammonia levels every 3-4 hours until normalized 1, 2
  • Monitor neurological status, including Glasgow Coma Scale 2, 3
  • Monitor electrolytes, blood glucose, arterial blood gases, and liver function tests 1, 4
  • Assess for signs of cerebral edema through clinical examination or imaging 2, 4

Reintroduction of Protein

  • Gradually reintroduce protein within 48 hours (by 0.25 g/kg daily, up to 1.5 g/kg daily) once ammonia levels decrease to 80-100 μmol/L 1, 3
  • Avoid prolonged protein restriction beyond 48 hours to prevent catabolism 1, 2

Common Pitfalls and Caveats

  • Delayed recognition and treatment can lead to irreversible neurological damage, including seizures, coma, and death 1, 6
  • Nitrogen scavengers will be dialyzed during CKRT but can still be effective when used concurrently 1, 2
  • Duration of hyperammonemic coma >3 days and plasma ammonia levels >1,000 μmol/l are poor prognostic factors 3, 7
  • Patients with recurrent hyperammonemia should be evaluated for underlying urea cycle disorders, even in adulthood 7, 8
  • Sodium benzoate and sodium phenylacetate should be administered via central venous catheter as peripheral administration may cause burns 4

References

Guideline

Treatment of Hyperammonemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Hyperammonemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperammonemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nonhepatic Hyperammonemia With Septic Shock: Case and Review of Literature.

Journal of investigative medicine high impact case reports, 2022

Research

Clinical practice: the management of hyperammonemia.

European journal of pediatrics, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.